|
Your search returned 250 studies:
- 3-D Transcranial Ultrasound Analysis Study - NCT00239525-27710
Conditions: Cerebrovascular Accident, Intracranial Hypertension
Location: Durham, NC
- A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities - NCT00935077-52242
Conditions: Hypertension - Asthma
Location: Iowa City, IA
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure - NCT01005290-
Conditions: Hypertension
Location: New York, NY
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90013
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90025
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90057
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90247
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Gardena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90505
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Torrance, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90630
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Cypress, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90806
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Long Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-91105
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Pasadena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92663
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Newport Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92844
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Garden Grove, CA
- A Pilot Observational Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients - NCT00952081-10031
Conditions: Hypertension - Brain Tumor - Epilepsy
Location: New York, NY
- A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension - NCT00850369-27710
Conditions: Pulmonary Hypertension - Sickle Cell Disease
Location: Durham, NC
- A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome - NCT00940966-25302
Conditions: Elevated Triglycerides - Systolic Hypertension - Insulin Resistance - Abdominal Obesity
Location: Charleston, WV
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-02111
Conditions: Hypertension, Pulmonary
Location: Boston, MA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-15212
Conditions: Hypertension, Pulmonary
Location: Pittsburgh, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-19141
Conditions: Hypertension, Pulmonary
Location: Philadelphia, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30030
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30033
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-32610
Conditions: Hypertension, Pulmonary
Location: Gainesville, FL
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-68131
Conditions: Hypertension, Pulmonary
Location: Omaha, NE
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-75390
Conditions: Hypertension, Pulmonary
Location: Dallas, TX
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85006
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85020
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92663
Conditions: Hypertension, Pulmonary
Location: Newport Beach, CA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92708
Conditions: Hypertension, Pulmonary
Location: Fountain Valley, CA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-95817
Conditions: Hypertension, Pulmonary
Location: Sacramento, CA
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20018
Conditions: Hypertension
Location: Washington, DC
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20032
Conditions: Hypertension
Location: Washington, DC
- A Study of Different Formulations of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma - NCT00967811-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives - NCT00825188-39216
Conditions: Obesity - Hypertension
Location: Jackson, MS
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-
Conditions: Pulmonary Hypertension
Location: Baltimore, MD
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-30342
Conditions: Pulmonary Hypertension
Location: Atlanta, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-35233
Conditions: Pulmonary Hypertension
Location: Birmingham, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-92103
Conditions: Pulmonary Hypertension
Location: San Diego, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-
Conditions: Pulmonary Hypertension
Location: Baltimore, MD
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02111
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30342
Conditions: Pulmonary Hypertension
Location: Atlanta, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-35233
Conditions: Pulmonary Hypertension
Location: Birmingham, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-55905
Conditions: Pulmonary Hypertension
Location: Rochester, MN
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90073
Conditions: Pulmonary Hypertension
Location: Los Angeles, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90502
Conditions: Pulmonary Hypertension
Location: Torrance, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6 - 17 Years of Age - NCT00834041-
Conditions: Hypertension
Location: Daytona Beach, FL
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-02114
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Boston, MA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-15212
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Pittsburgh, PA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-15213
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Pittsburgh, PA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-21224
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Baltimore, MD
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-22042
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Falls Church, VA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-33125
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Miami, FL
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-44106
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Cleveland, OH
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-45014
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Fairfield, OH
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-55905
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Rochester, MN
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-63110
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: St. Louis, MO
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-90502
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Torrance, CA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-92103
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: San Diego, CA
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction - NCT01065454-95817
Conditions: Hypertension, Pulmonary - Ventricular Dysfunction, Left
Location: Sacramento, CA
- Acupuncture and Laser Acupoint Treatment on Hypertension - NCT00459680-63017
Conditions: Hypertension
Location: Chesterfield, MO
- ADMA Levels in End-Stage Renal Disease - NCT00350974-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-20892
Conditions: Hypertension, Pulmonary
Location: Bethesda, MD
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-22042
Conditions: Hypertension, Pulmonary
Location: Falls Church, VA
- After Discharge Management of Low Income Frail Elderly - NCT00328848-44304
Conditions: Heart Failure, Congestive - Coronary Arteriosclerosis - Atrial Fibrillation - Cerebrovascular Accident - Pulmonary Disease, Chronic Obstructive - Diabetes Mellitus - Hypertension - Osteoarthritis - Osteoporosis
Location: Akron, OH
- Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension - NCT00980031-68131
Conditions: Myocardial Remodeling
Location: Omaha, NE
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-02126
Conditions: Hypertension
Location: Mattapan, MA
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-20110
Conditions: Hypertension
Location: Manassas, VA
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-33143
Conditions: Hypertension
Location: South Miami, FL
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-72201
Conditions: Hypertension
Location: Little Rock, AR
- Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension - NCT00942994-98133
Conditions: Hypertension
Location: Seattle, WA
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide - NCT00356265-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Chapel Hill, NC
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-29466
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Charleston, SC
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-40202
Conditions: Hypertension
Location: Louisville, KY
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-44106
Conditions: Hypertension
Location: Cleveland, OH
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-72202
Conditions: Hypertension
Location: Little Rock, AR
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-84132
Conditions: Hypertension
Location: Salt Lake City, UT
- An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects - NCT00811564-
Conditions: Glaucoma - Ocular Hypertension
Location: Slingerlands, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Miami, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-02111
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Boston, MA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-02118
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Boston, MA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-03756
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Lebanon, NH
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-10029
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: New York, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-10032
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: New York, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-11040
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: New Hyde Park, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-11501
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Mineola, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-12208
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Albany, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-12512
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Pittsburgh, PA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-15213
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Pittsburgh, PA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-19104
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Philadelphia, PA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-21205
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Baltimore, MD
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-22042
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Falls Church, VA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-27710
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Durham, NC
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-29605
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Greenville, SC
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-30030
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Decatur, GA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-32610
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Gainesville, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-33331
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Weston, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-33756
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Clearwater, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-34233
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Sarasota, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-34239
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Sarasota, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-35294
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Birmingham, AL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-37232
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Nashville, TN
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-43210
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Columbus, OH
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-44195
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Cleveland, OH
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-45219
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Cincinnati, OH
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-60637
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Chicago, IL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-63110
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: St Louis, MO
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-68131
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Omaha, NE
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-75390
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Dallas, CA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-77030
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Houston, TX
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-80045
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Aurora, CO
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-85013
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Phoenix, AZ
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-90095
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Los Angeles, CA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-92103
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: San Diego, CA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-94143
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: San Francisco, CA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-95817
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Davis, CA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-98201
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Everett, WA
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-48202
Conditions: Pulmonary Arterial Hypertension
Location: Detroit, MI
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-78229
Conditions: Pulmonary Arterial Hypertension
Location: San Antonio, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-90073
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Assessing Outcome After H-Graft Shunt Placement - NCT00519610-33606
Conditions: Portal Hypertension
Location: Tampa, FL
- Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) - NCT00455403-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Azilsartan Medoxomil Study in Hypertensive Children - NCT01078376-
Conditions: Hypertension
Location: Cleveland, OH
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions - NCT00081731-43614
Conditions: Atherosclerosis - Cardiovascular Diseases - Hypertension, Renovascular - Renal Artery Obstruction
Location: Toledo, OH
- Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension - NCT00913094-48201
Conditions: Hypertension
Location: Detroit, MI
- Biomarkers in the Evaluation of Chronic Lung Disease - NCT00926523-11040
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension - Interstitial Lung Disease
Location: New Hyde Park, NY
- Biomarkers of Metabolic Syndrome and Prediabetes - NCT01086137-24901
Conditions: Metabolic Syndrome - Diabetes - Prediabetes - Hypertension
Location: Lewisburg, WV
- Blood Pressure Control in African Americans - NCT00233220-10032
Conditions: Cardiovascular Diseases - Hypertension
Location: New York, NY
- Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab - NCT01076140-39216
Conditions: Hypertension
Location: Jackson, MS
- Body Volume Regulation in Pulmonary Arterial Hypertenison With Right Ventricular Failure - NCT00811486-80262
Conditions: Right Heart Failure - Pulmonary Hypertension
Location: Denver, CO
- B-type Natriuretic Peptide (BNP) in Human Hypertension - NCT00953472-55905
Conditions: Hypertension Stage 1
Location: Rochester, MN
- Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril - NCT00657241-14215
Conditions: Hypertension
Location: Buffalo, NY
- Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients - NCT00125229-78229
Conditions: Traumatic Brain Injury - Intracranial Hypertension
Location: San Antonio, TX
- Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy - NCT00452283-80045
Conditions: Glaucoma - Pulmonary Hypertension
Location: Aurora, CO
- Chiropractic for Hypertension in Patients - NCT01020435-33140
Conditions: Hypertension
Location: Miami, FL
- Chiropractic for Hypertension in Patients - NCT01020435-52722
Conditions: Hypertension
Location: Bettendorf, IA
- Chiropractic for Hypertension in Patients - NCT01020435-52803
Conditions: Hypertension
Location: Davenport, IA
- Chloroquine to Treat People With Metabolic Syndrome (ARCH-MS) - NCT00455325-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-60614
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Chicago, IL
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-90027
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Los Angeles, CA
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-94143
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: San Francisco, CA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-11794
Conditions: Hypertension - Heart Failure
Location: Stony Brook, NY
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-27710
Conditions: Hypertension - Heart Failure
Location: Durham, NC
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-36106
Conditions: Hypertension - Heart Failure
Location: Montgomery, AL
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-37232
Conditions: Hypertension - Heart Failure
Location: Nashville, TN
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44109
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44195
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-45267
Conditions: Hypertension - Heart Failure
Location: Cincinnati, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-48073
Conditions: Hypertension - Heart Failure
Location: Royal Oak, MI
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-48202
Conditions: Hypertension - Heart Failure
Location: Detroit, MI
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-63110
Conditions: Hypertension - Heart Failure
Location: St. Louis, MO
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-63141
Conditions: Hypertension - Heart Failure
Location: St. Louis, MO
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70112
Conditions: Hypertension - Heart Failure
Location: New Orleans, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70805
Conditions: Hypertension - Heart Failure
Location: Baton Rouge, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-75390
Conditions: Hypertension - Heart Failure
Location: Dallas, TX
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-90301
Conditions: Hypertension - Heart Failure
Location: Inglewood, CA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-10032
Conditions: Hypertension - Hemorrhage
Location: New York, NY
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-19107
Conditions: Hypertension - Hemorrhage
Location: Philadelphia, PA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-20010
Conditions: Hypertension - Hemorrhage
Location: Washington, DC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-21287
Conditions: Hypertension - Hemorrhage
Location: Baltimore, MD
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27405
Conditions: Hypertension - Hemorrhage
Location: Greensboro, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27710
Conditions: Hypertension - Hemorrhage
Location: Durham, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425A
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425B
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-43210
Conditions: Hypertension - Hemorrhage
Location: Columbus, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-44195
Conditions: Hypertension - Hemorrhage
Location: Cleveland, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-48202
Conditions: Hypertension - Hemorrhage
Location: Detroit, MI
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-77030
Conditions: Hypertension - Hemorrhage
Location: Houston, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-78229
Conditions: Hypertension - Hemorrhage
Location: San Antonio, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-84157
Conditions: Hypertension - Hemorrhage
Location: Murray, UT
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-96813
Conditions: Hypertension - Hemorrhage
Location: Honolulu, HI
- Clinical Decision Support Consortium - NCT00853619-02481
Conditions: Diabetes - Coronary Artery Disease - Hypertension
Location: Wellesley, MA
- Clinical Validation of the Tiba Medical Ambulo 2400 ABPM According to the ISO 80601-2-30 Standard in Adults, Adolescents, and Children - NCT00944983-38105
Conditions: Hypertension
Location: Memphis, TN
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-02115
Conditions: Pulmonary Arterial Hypertension
Location: Boston, MA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-10032
Conditions: Pulmonary Arterial Hypertension
Location: New York, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-14203
Conditions: Pulmonary Arterial Hypertension
Location: Buffalo, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213A
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213B
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-19713
Conditions: Pulmonary Arterial Hypertension
Location: Newark, DE
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-21201
Conditions: Pulmonary Arterial Hypertension
Location: Baltimore, MD
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-23507
Conditions: Pulmonary Arterial Hypertension
Location: Norfolk, VA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30030
Conditions: Pulmonary Arterial Hypertension
Location: Decatur, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30322
Conditions: Pulmonary Arterial Hypertension
Location: Atlanta, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-32258
Conditions: Pulmonary Arterial Hypertension
Location: Jacksonville, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33136
Conditions: Pulmonary Arterial Hypertension
Location: Miami, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33331
Conditions: Pulmonary Arterial Hypertension
Location: Weston, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33756
Conditions: Pulmonary Arterial Hypertension
Location: Clearwater, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-34239
Conditions: Pulmonary Arterial Hypertension
Location: Sarasota, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-35294
Conditions: Pulmonary Arterial Hypertension
Location: Birmingham, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-36617
Conditions: Pulmonary Arterial Hypertension
Location: Mobile, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-40202
Conditions: Pulmonary Arterial Hypertension
Location: Louisville, KY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-43210
Conditions: Pulmonary Arterial Hypertension
Location: Columbus, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-44195
Conditions: Pulmonary Arterial Hypertension
Location: Cleveland, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-53226
Conditions: Pulmonary Arterial Hypertension
Location: Milwaukee, WI
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-55905
Conditions: Pulmonary Arterial Hypertension
Location: Rochester, MN
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-63110
Conditions: Pulmonary Arterial Hypertension
Location: St. Louis, MO
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-73112
Conditions: Pulmonary Arterial Hypertension
Location: Oklahoma City, OK
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-84604
Conditions: Pulmonary Arterial Hypertension
Location: Provo, UT
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90048
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90095
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-97220
Conditions: Pulmonary Arterial Hypertension
Location: Portland, OR
- Combined Renin Inhibition/Beta-blockade - NCT00627861-10021
Conditions: Hypertension
Location: New York, NY
- Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes - NCT00379652-02115
Conditions: Hypertension - Diabetes Mellitis
Location: Boston, MA
- Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes - NCT00379652-02118
Conditions: Hypertension - Diabetes Mellitis
Location: Boston, MA
- Comparative Effects of Nebivolol and Metoprolol on Femal Sexual Function - NCT00995072-32223
Conditions: Hypertension - Female Sexual Dysfunction
Location: Jacksonville, FL
- Comparative Effects of Nebivolol Versus Placebo on Sodium Sensitivity of Blood Pressure in Hispanic Postmenopausal Women With Hypertension - NCT00992056-33136
Conditions: Hypertension
Location: 1500 NW 12th Ave 15-West. Miam, FL
- Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects - NCT00735449-
Conditions: Glaucoma - Ocular Hypertension
Location: Newark, NJ
- Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate - NCT00849810-39216
Conditions: Hypertension
Location: Jackson, MS
- Comparison Fetal Hemodynamic Measurements Antihypertensive Versus Control - NCT00759278-13202
Conditions: Hypertension - Pregnancy
Location: Syracuse, NY
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty - NCT00567411-20307
Conditions: Glaucoma - Ocular Hypertension
Location: Washington, DC
- Coreg CR, Blood Vessel Stiffness and Blood Vessel Function - NCT00732511-11203
Conditions: Endothelial Function - Diabetes Mellitus - Hypertension
Location: Brooklyn, NY
- Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort - NCT00344903-75390
Conditions: Atherosclerosis - Congestive Heart Failure - Left Ventricular Hypertrophy - Diabetes Mellitus - Hypertension - Obesity - Metabolic Syndrome X - Myocardial Infarction
Location: Dallas, TX
- DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study) - NCT00865683-45229
Conditions: Overweight and Obesity - Insulin Resistance - Diabetes, Gestational - Hypertension in Pregnancy - Pre-Eclampsia
Location: Cincinnati, OH
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-06516
Conditions: Obstructive Sleep Apnea - Hypertension
Location: West Haven, CT
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-46202
Conditions: Obstructive Sleep Apnea - Hypertension
Location: Indianapolis, IN
- Does Sildenafil Increase Exercise Performance in Air Pollution? - NCT00808912-18509
Conditions: Pulmonary Hypertension - Pulmonary Artery Pressure - Exercise Performance - Air Pollution
Location: Scranton, PA
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-90502
Conditions: Pulmonary Arterial Hypertension
Location: Torrance, CA
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension - NCT00581607-
Conditions: Sarcoidosis - Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension - NCT00581607-45267
Conditions: Sarcoidosis - Pulmonary Arterial Hypertension
Location: Cincinnati, OH
- DuoTrav APS Versus XALACOM® in Ocular Surface Health - NCT00912054-76134
Conditions: Open Angle Glaucoma - Ocular Hypertension
Location: Fort Worth, TX
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-02118
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Boston, MA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-06030
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Farmington, CT
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-11042
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Lake Success, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-12206
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Albany, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-14618
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Rochester, NY
|
|